Oral delivery of calcitonin-ion pairs: In vivo proof of concept for a highly lipophilic counterion.
Hydrophobic ion pairing
Lipophilic counterions
Oral peptide delivery
Salmon calcitonin
Self-emulsifying drug delivery systems
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Jan 2023
25 Jan 2023
Historique:
received:
06
09
2022
revised:
28
11
2022
accepted:
05
12
2022
pubmed:
18
12
2022
medline:
14
1
2023
entrez:
17
12
2022
Statut:
ppublish
Résumé
Hydrophobic ion pairing and subsequent incorporation into self-emulsifying drug delivery systems (SEDDS) is a promising strategy to orally deliver hydrophilic macromolecular drugs. Within this study, hydrophobic ion pairs (HIP) between salmon calcitonin (sCT) and highly lipophilic sulfosuccinate counterions were formed and compared to frequently applied commercially available counterions. Bis(isotridecyl) sulfosuccinate resulted in HIPs of the highest lipophilicity and in significantly higher solubility in lipophilic co-solvents. Thus, bis(isotridecyl) sulfosuccinate allowed efficient solubilization of sCT in a SEDDS preconcentrate based on a lipophilic co-solvent and an indigestible lipid, but omitting hydrophilic co-solvents. In addition to the increased solubility in the lipidic matrix, markedly reduced dissociation in biorelevant media resulted in high distribution coefficients between oil droplet and FaSSGF or FaSSIF (logD) of 2.98 ± 0.12 or 2.77 ± 0.14, respectively. The composition of the lipidic matrix preserved integrity of the oil droplets after emulsification and subsequent lipolysis, allowing to fully exploit the potential of the HIP attributed to the high logD. Oral administration of the HIP-loaded SEDDS resulted in an excellent relative pharmacological activity of 13.8 ± 5.6 % measured as hypocalcaemic effect in rats.
Identifiants
pubmed: 36528188
pii: S0378-5173(22)01031-6
doi: 10.1016/j.ijpharm.2022.122476
pii:
doi:
Substances chimiques
thiosuccinic acid
X769MZ3BBT
Calcitonin
9007-12-9
Emulsions
0
Succinates
0
Bone Density Conservation Agents
0
Solvents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122476Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.